JAK inhibitor derivatives, pharmaceutical compositions and uses thereof
TW202633888APending Publication Date: 2026-08-16VIVAVISION (SHANGHAI) LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW115104259
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-02-14
- Filing Date
- 2026-02-03
- Publication Date
- 2026-08-16
Abstract
This invention provides a JAK inhibitor derivative, comprising: a compound represented by Formula (II) or Formula (II') or a stereoisomer, or a pharmaceutically acceptable salt thereof. The compound can completely convert into the compound of Formula (I) in the suprachoroidal space after injection, thereby exerting a therapeutic effect on posterior uveitis. Additionally, it can remain in the suprachoroidal space for more than
Need to check novelty before this filing date? Find Prior Art